• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

反流性疾病和食管腺癌中的微生物群

Microbiome in reflux disorders and esophageal adenocarcinoma.

作者信息

Yang Liying, Chaudhary Noami, Baghdadi Jonathan, Pei Zhiheng

机构信息

From the *Department of Medicine, New York University School of Medicine, New York, NY; and †Department of Veterans Affairs New York Harbor Healthcare System, New York, NY 10010; Departments of Medicine and Pathology, New York University School of Medicine, New York, NY.

出版信息

Cancer J. 2014 May-Jun;20(3):207-10. doi: 10.1097/PPO.0000000000000044.

DOI:10.1097/PPO.0000000000000044
PMID:24855009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4120752/
Abstract

The incidence of esophageal adenocarcinoma has increased dramatically in the United States and Europe since the 1970s without apparent cause. Although specific host factors can affect risk of disease, such a rapid increase in incidence must be predominantly environmental. In the stomach, infection with Helicobacter pylori has been linked to chronic atrophic gastritis, an inflammatory precursor of gastric adenocarcinoma. However, the role of H. pylori in the development of esophageal adenocarcinoma is not well established. Meanwhile, several studies have established that a complex microbiome in the distal esophagus might play a more direct role. Transformation of the microbiome in precursor states to esophageal adenocarcinoma-reflux esophagitis and Barrett metaplasia-from a predominance of gram-positive bacteria to mostly gram-negative bacteria raises the possibility that dysbiosis is contributing to pathogenesis. However, knowledge of the microbiome in esophageal adenocarcinoma itself is lacking. Microbiome studies open a new avenue to the understanding of the etiology and pathogenesis of reflux disorders.

摘要

自20世纪70年代以来,美国和欧洲的食管腺癌发病率急剧上升,原因不明。虽然特定的宿主因素会影响患病风险,但发病率如此迅速的上升主要必定是环境因素所致。在胃部,幽门螺杆菌感染与慢性萎缩性胃炎有关,而慢性萎缩性胃炎是胃腺癌的一种炎症前驱病变。然而,幽门螺杆菌在食管腺癌发生过程中的作用尚未明确。与此同时,多项研究证实,远端食管中的复杂微生物群可能发挥更直接的作用。从前体状态(反流性食管炎和巴雷特化生)到食管腺癌,微生物群从以革兰氏阳性菌为主转变为大多为革兰氏阴性菌,这增加了生态失调导致发病机制的可能性。然而,目前缺乏对食管腺癌本身微生物群的了解。微生物群研究为理解反流性疾病的病因和发病机制开辟了一条新途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ad0/4120752/9b6b3e1d4da8/nihms608634f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ad0/4120752/9b6b3e1d4da8/nihms608634f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ad0/4120752/9b6b3e1d4da8/nihms608634f1.jpg

相似文献

1
Microbiome in reflux disorders and esophageal adenocarcinoma.反流性疾病和食管腺癌中的微生物群
Cancer J. 2014 May-Jun;20(3):207-10. doi: 10.1097/PPO.0000000000000044.
2
Potential Role of the Microbiome in Barrett's Esophagus and Esophageal Adenocarcinoma.微生物群落在巴雷特食管和食管腺癌中的潜在作用
Dig Dis Sci. 2016 Aug;61(8):2217-2225. doi: 10.1007/s10620-016-4155-9. Epub 2016 Apr 11.
3
Microbiome, innate immunity, and esophageal adenocarcinoma.微生物组、固有免疫与食管腺癌
Clin Lab Med. 2014 Dec;34(4):721-32. doi: 10.1016/j.cll.2014.08.001. Epub 2014 Sep 26.
4
Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma.巴雷特食管和食管腺癌中食管微生物群的改变。
World J Gastroenterol. 2019 May 14;25(18):2149-2161. doi: 10.3748/wjg.v25.i18.2149.
5
Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus.分子途径:微生物组改变在食管炎和 Barrett 食管中的发病机制和临床意义。
Clin Cancer Res. 2012 Apr 15;18(8):2138-44. doi: 10.1158/1078-0432.CCR-11-0934. Epub 2012 Feb 16.
6
Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma.微生物群与食管腺癌化学预防的潜在靶点
Semin Oncol. 2016 Feb;43(1):86-96. doi: 10.1053/j.seminoncol.2015.09.005. Epub 2015 Sep 7.
7
The Esophageal Microbiome in Health and Disease.健康与疾病状态下的食管微生物群
Curr Gastroenterol Rep. 2018 Aug 1;20(8):39. doi: 10.1007/s11894-018-0642-9.
8
Interactions between Helicobacter pylori and gastroesophageal reflux disease.幽门螺杆菌与胃食管反流病之间的相互作用。
Dis Esophagus. 1998 Oct;11(4):203-9. doi: 10.1093/dote/11.4.203.
9
Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome.远端食管的炎症和肠化生与微生物群的改变有关。
Gastroenterology. 2009 Aug;137(2):588-97. doi: 10.1053/j.gastro.2009.04.046. Epub 2009 Apr 23.
10
Barrett's esophagus and intestinal metaplasia of gastric cardia: prevalence, clinical, endoscopic and histological features.巴雷特食管与贲门肠化生:患病率、临床、内镜及组织学特征
J Gastrointestin Liver Dis. 2014 Mar;23(1):19-25.

引用本文的文献

1
The Potential Role of -Related Mast Cell Activation in the Progression from Gastroesophageal Reflux to Barrett's Esophagus and Esophageal Adenocarcinoma.与……相关的肥大细胞激活在胃食管反流进展为巴雷特食管和食管腺癌过程中的潜在作用 。 注:原文中“-Related”处有缺失内容,以上是根据现有内容尽量准确翻译的结果。
Microorganisms. 2025 Aug 12;13(8):1883. doi: 10.3390/microorganisms13081883.
2
The role of the esophageal and intestinal microbiome in gastroesophageal reflux disease: past, present, and future.食管和肠道微生物群在胃食管反流病中的作用:过去、现在与未来
Front Immunol. 2025 Feb 21;16:1558414. doi: 10.3389/fimmu.2025.1558414. eCollection 2025.
3

本文引用的文献

1
Pearls and pitfalls of genomics-based microbiome analysis.基于基因组学的微生物组分析的要点与陷阱
Emerg Microbes Infect. 2012 Dec;1(12):e45. doi: 10.1038/emi.2012.41.
2
Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality?胃食管反流病、巴雷特食管和食管癌中食管细菌生物膜的变化:关联还是因果关系?
Aliment Pharmacol Ther. 2013 Jun;37(11):1084-92. doi: 10.1111/apt.12317. Epub 2013 Apr 22.
3
Characterization of bacterial biota in the distal esophagus of Japanese patients with reflux esophagitis and Barrett's esophagus.
Diagnosis and treatment of patients with gastroesophageal reflux disease - a systematic review of cost-effectiveness and economic burden.
胃食管反流病患者的诊断和治疗——成本效益和经济负担的系统评价。
BMC Health Serv Res. 2024 Nov 6;24(1):1351. doi: 10.1186/s12913-024-11781-8.
4
The interplay between alterations in esophageal microbiota associated with Th17 immune response and impaired LC20 phosphorylation in achalasia.食管微生物群与 Th17 免疫反应改变以及 Achalasia 中 LC20 磷酸化受损之间的相互作用。
J Gastroenterol. 2024 May;59(5):361-375. doi: 10.1007/s00535-024-02088-w. Epub 2024 Mar 12.
5
Respiratory infectious burden in a cohort of antibody deficiency patients treated with immunoglobulin replacement therapy: The impact of lung pathology and gastroesophageal reflux disease.接受免疫球蛋白替代疗法的抗体缺陷患者队列中的呼吸道感染负担:肺部病理学和胃食管反流病的影响。
J Allergy Clin Immunol Glob. 2023 Jul 1;2(4):100133. doi: 10.1016/j.jacig.2023.100133. eCollection 2023 Nov.
6
Proton pump inhibitors induced fungal dysbiosis in patients with gastroesophageal reflux disease.质子泵抑制剂导致胃食管反流病患者真菌失调。
Front Cell Infect Microbiol. 2023 Aug 17;13:1205348. doi: 10.3389/fcimb.2023.1205348. eCollection 2023.
7
Human Microbiota in Esophageal Adenocarcinoma: Pathogenesis, Diagnosis, Prognosis and Therapeutic Implications.食管腺癌中的人类微生物群:发病机制、诊断、预后及治疗意义
Front Microbiol. 2022 Jan 14;12:791274. doi: 10.3389/fmicb.2021.791274. eCollection 2021.
8
Gut Microbiota for Esophageal Cancer: Role in Carcinogenesis and Clinical Implications.食管癌的肠道微生物群:在致癌作用中的作用及临床意义
Front Oncol. 2021 Oct 18;11:717242. doi: 10.3389/fonc.2021.717242. eCollection 2021.
9
Host-Microbiota Interactions in the Esophagus During Homeostasis and Allergic Inflammation.食管在稳态和变应性炎症过程中的宿主-微生物群相互作用。
Gastroenterology. 2022 Feb;162(2):521-534.e8. doi: 10.1053/j.gastro.2021.10.002. Epub 2021 Oct 8.
10
Role of Microbial Infection-Induced Inflammation in the Development of Gastrointestinal Cancers.微生物感染诱导的炎症在胃肠道癌症发生发展中的作用
Medicines (Basel). 2021 Aug 17;8(8):45. doi: 10.3390/medicines8080045.
日本反流性食管炎和巴雷特食管患者食管远端细菌群的特征。
BMC Infect Dis. 2013 Mar 11;13:130. doi: 10.1186/1471-2334-13-130.
4
Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus.分子途径:微生物组改变在食管炎和 Barrett 食管中的发病机制和临床意义。
Clin Cancer Res. 2012 Apr 15;18(8):2138-44. doi: 10.1158/1078-0432.CCR-11-0934. Epub 2012 Feb 16.
5
The human oral microbiome.人类口腔微生物组。
J Bacteriol. 2010 Oct;192(19):5002-17. doi: 10.1128/JB.00542-10. Epub 2010 Jul 23.
6
Esophageal adenocarcinoma incidence: are we reaching the peak?食管腺癌发病率:我们是否已达到峰值?
Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1468-70. doi: 10.1158/1055-9965.EPI-10-0012. Epub 2010 May 25.
7
Diversity of 16S rRNA genes within individual prokaryotic genomes.单个原核生物基因组中 16S rRNA 基因的多样性。
Appl Environ Microbiol. 2010 Jun;76(12):3886-97. doi: 10.1128/AEM.02953-09. Epub 2010 Apr 23.
8
Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis.胃食管反流病中的炎症介质:对食管动力、纤维化和癌变的影响。
Am J Physiol Gastrointest Liver Physiol. 2010 May;298(5):G571-81. doi: 10.1152/ajpgi.00454.2009. Epub 2010 Mar 18.
9
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis.巴雷特食管和食管腺癌:新的综合治疗时机。
Nat Rev Cancer. 2010 Feb;10(2):87-101. doi: 10.1038/nrc2773.
10
Recent findings on the viable but nonculturable state in pathogenic bacteria.近期关于致病菌中活的但不可培养状态的发现。
FEMS Microbiol Rev. 2010 Jul;34(4):415-25. doi: 10.1111/j.1574-6976.2009.00200.x. Epub 2009 Nov 24.